TANG CAPITAL MANAGEMENT LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001232621

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth Tilt how tags are computed

Q3 2024 · 154 positions · Total reported value $1.40B · Top-10 concentration 35.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 15.2% · 5 new · 1 cut · 1 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.5% · vs SPY -10.6% · Prev Value $2.20B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.0% · vs SPY -5.2% · Latest Value $2.17B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2024 13F filing, TANG CAPITAL MANAGEMENT LLC disclosed 154 equity positions with a combined reported value of $1.40B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 35.9% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt.

The largest disclosed positions as of Q3 2024 were EOLS ($78.53M), TARS ($74.16M), AUPH ($52.99M). By sector, the heaviest allocations are Health Care 76.2%, Technology 2.5%. Versus the prior quarter, allocation shifted toward Other (+0.7pp) and away from Health Care (-0.6pp).

Versus the prior quarter, TANG CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 1 and fully exited 1, a turnover rate of 15.2% of positions. The portfolio's overlap with the prior quarter was 73% of names.

The largest new positions opened in Q3 2024 were BNTX ($32.07M), RLAY ($25.26M), ITOS ($24.58M).

Of the 1 positions fully exited versus the prior quarter, the largest were LLY ($24.45M), INBX ($2.37M), DEI ($2.28M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • BNTX BIONTECH SE · $32.07M
  • RLAY RELAY THERAPEUTICS INC · $25.26M
  • ITOS ITEOS THERAPEUTICS INC · $24.58M
  • NBIX NEUROCRINE BIOSCIENCES INC · $17.28M
  • NVAX NOVAVAX INC · $12.63M
  • CRBP CORBUS PHARMACEUTICALS HLDGS · $12.38M
  • ELAN ELANCO ANIMAL HEALTH INC · $8.81M
  • HLVX HILLEVAX INC · $8.66M

Fully Exited (vs previous quarter)

  • LLY ELI LILLY & CO · prev qtr: $24.45M
  • INBX INHIBRX BIOSCIENCES INC · prev qtr: $2.37M
  • DEI DOUGLAS EMMETT INC · prev qtr: $2.28M
  • ADAPY ADAPTIMMUNE THERAPEUTICS PLC · prev qtr: $1.70M
  • QNCX QUINCE THERAPEUTICS INC · prev qtr: $1.12M
  • DERM JOURNEY MED CORP · prev qtr: $836.54K · history
  • ALGS ALIGOS THERAPEUTICS INC · prev qtr: $577.50K
  • MOLN MOLECULAR PARTNERS AG · prev qtr: $18.07K

Insider Transactions (Form 4)

Latest TANG CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-10 Buy Boundless Bio, Inc. 249 $2.40 SEC filing
2026-11-06 Buy Boundless Bio, Inc. 1,700 $2.40 SEC filing
2026-11-05 Buy Boundless Bio, Inc. 8,390 $2.40 SEC filing
2026-11-04 Buy Boundless Bio, Inc. 517 $2.40 SEC filing
2026-11-03 Buy Boundless Bio, Inc. 2,255 $2.40 SEC filing
2026-10-27 Buy Boundless Bio, Inc. 10,707 $2.40 SEC filing
2026-10-26 Buy Boundless Bio, Inc. 9,606 $2.38 SEC filing
2026-10-23 Buy Boundless Bio, Inc. 6,234 $2.38 SEC filing

All insider transactions →

Fund Profile

Tang Capital Management is an SEC-registered 13F filer. As of Q3 2026 it reported 45 US equity positions with a combined value of $2.17B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 45 positions · $2.17B reported value (Q3 2026)
  • Top 10 holdings = 64.3% of reported value
  • Largest position: AUPH (AURINIA PHARMACEUTICALS INC) at 9.7%
  • Average position size: $48.31M

Sector Tilt

  • Health Care 89.7%
  • Information Technology 1.5%
  • (classified holdings cover 91% of value)

Quarterly Activity

  • Q3 2026: 5 new, 12 added, 1 reduced, 1 exited
  • 27 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 76.2%
Technology 2.5%
Materials 0.1%
Financials 0.1%
Other 19.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 4.85M $78.53M 5.61%
5.61%
Hold
2 2.25M $74.16M 5.30%
5.30%
Hold
3 7.23M $52.99M 3.79%
3.79%
Add
4 2.24M $51.03M 3.65%
3.65%
Add
5 1.29M $50.20M 3.59%
3.59%
Reduce
6 4.32M $50.04M 3.58%
3.58%
Add
7 1.33M $44.58M 3.19%
3.19%
Hold
8 1.11M $34.42M 2.46%
2.46%
Add
9 300.00K $34.28M 2.45%
2.45%
Hold
10 270.00K $32.07M 2.29%
2.29%
New
11 450.00K $26.85M 1.92%
1.92%
Hold
12 700.00K $25.97M 1.85%
1.85%
Hold
13 3.57M $25.26M 1.80%
1.80%
New
14 2.41M $24.58M 1.76%
1.76%
New
15 2.73M $23.20M 1.66%
1.66%
Add
16 1.50M $23.07M 1.65%
1.65%
Hold
17 300.00K $21.95M 1.57%
1.57%
Hold
18 1.90M $21.17M 1.51%
1.51%
Reduce
19 700.00K $20.15M 1.44%
1.44%
Add
20 450.00K $18.40M 1.31%
1.31%
Add
21 766.94K $18.21M 1.30%
1.30%
Add
22 147.73K $17.94M 1.28%
1.28%
Add
23 150.00K $17.28M 1.24%
1.24%
New
24 2.75M $16.89M 1.21%
1.21%
Hold
25 1.23M $16.13M 1.15%
1.15%
Hold
26 628.61K $15.71M 1.12%
1.12%
Add
27 140.00K $15.60M 1.11%
1.11%
Hold
28 4.61M $15.43M 1.10%
1.10%
Add
29 921.14K $15.42M 1.10%
1.10%
Hold
30 25.86K $14.80M 1.06%
1.06%
Add
31 750.00K $13.85M 0.99%
0.99%
Hold
32 1.10M $13.80M 0.99%
0.99%
Hold
33 1.20M $13.15M 0.94%
0.94%
Add
34 2.50M $12.97M 0.93%
0.93%
Add
35 700.75K $12.93M 0.92%
0.92%
Add
36 1.40M $12.85M 0.92%
0.92%
Add
37 1.00M $12.63M 0.90%
0.90%
New
38 266.50K $12.52M 0.89%
0.89%
Reduce
39 600.00K $12.38M 0.88%
0.88%
New
40 8.22M $11.83M 0.84%
0.84%
Hold
41 150.00K $11.69M 0.83%
0.83%
Hold
42 281.20K $11.25M 0.80%
0.80%
Hold
43 2.35M $11.04M 0.79%
0.79%
Add
44 720.00K $10.53M 0.75%
0.75%
Hold
45 7.81M $9.22M 0.66%
0.66%
Hold
46 3.90M $8.93M 0.64%
0.64%
Add
47 600.00K $8.81M 0.63%
0.63%
New
48 4.92M $8.66M 0.62%
0.62%
New
49 1.56M $8.33M 0.59%
0.59%
Reduce
50 37.00K $8.31M 0.59%
0.59%
Hold

FAQ

What did TANG CAPITAL MANAGEMENT LLC buy in 2024-Q3?

In its 2024-Q3 13F filing, TANG CAPITAL MANAGEMENT LLC reported 154 equity positions worth $1.40B in aggregate; its largest disclosed positions were EOLS ($78.53M), TARS ($74.16M), AUPH ($52.99M).

How large is TANG CAPITAL MANAGEMENT LLC's portfolio?

TANG CAPITAL MANAGEMENT LLC reported $1.40B of long equity holdings across 154 positions as of 2024-Q3. Top-10 holdings account for 35.9% of reported value.

What is TANG CAPITAL MANAGEMENT LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tang-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →